Dermipsor Reports Positive Phase 2b Results Showing Efficacy and Synergy of its Leading Product DPS-101, a Non- Steroidal Topical Combination Drug to Treat Psoriasis

29.10.2008 – The data showed statistical significant efficacy in most arms.
Based on these results the company expects to initiate a pivotal Phase 3 study in 2011

Dermipsor Signs a Strategic Drug Development Collaboration with VA Boston Research Institute

07.10.2008 – Scalp Psoriasis Phase 2 Clinical Trial will be performed under this collaboration.

Dermipsor Completes a Bridge Investment

22.06.2008 – Proceeds will fund preparations for its lead Phase 3 study, as well as a Phase 2 study with an additional product

Dermipsor Appoints Dr. Oren M. Becker as its Active Chairman

14.04.2008 – Appointment Marks Growth of the Company as it is about to start Phase III clinical Studies